Digitizing the Value Chain for Life Sciences
The life sciences industry is in the midst of a transformation, bringing both opportunities and challenges. A bright future for the industry most likely lies ahead, due to increased healthcare consumption by aging populations in developed countries and a growing middle class in emerging markets, along with the rapid pace of scientific and technological breakthroughs. However, complications arise from shifting healthcare profit pools driven by demand for better health outcomes — thereby increasing digital disruption in the healthcare ecosystem — and a more engaged and educated healthcare consumer. Therefore, companies need to consider new strategies, business models, processes and innovative ways of using data.
Our life sciences strategy is based on a fundamental assumption that digital technologies and services present disruptive opportunities for life sciences companies to thrive in an emerging digital healthcare ecosystem. This strategy recognizes the significant shift from product to consumer as the market driver.
Leveraging our IP and next-generation technologies in cloud, mobility, advanced analytics and digital services, we are leading the life sciences industry’s digital transformation across the value chain:
Regulatory Affairs and Operations – Digitizing the regulatory process and information management from research and development (R&D) through post-market surveillance
Supply Chain Transparency, Flexibility and Responsiveness – To optimize time-to-clinical site in clinical trials, time-to-patients across the globe, and mitigate post-market fraud and counterfeiting risks
Agile and Secure Infrastructure – To help drive R&D collaboration platforms to facilitate breakthroughs and easy, low-cost access to mission-critical applications across the enterprise
Analytics – To drive insights across each point in the value chain and across the enterprise